The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis

Clinical Cancer Research

Volumn 9, Issue 5, 2003, Pages 1885-1897

  Minter, Helena A ^a   Eveson, John W ^a   Huntley, Suzanne ^a   Elder, Douglas J E ^a   Hague, Angela ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INVOLUCRIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; SYNTHETASE;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STAGING; CARCINOMA CELL; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EPITHELIAL CELLS; HUMANS; ISOENZYMES; KERATINOCYTES; MEMBRANE PROTEINS; MOUTH NEOPLASMS; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONAMIDES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037652020     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Thun, M. J., Henley, S. J., and Patrono, C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. (Bethesda), 94: 252-266, 2002.
2. Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., Van De Putte, L. B., and Lipsky, P. E. Cyclooxygenase in biology and disease. FASEB J., 12: 1063-1073, 1998.
3. Kelley, D. J., Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., Ramonetti, J. T., and Dannenberg, A. J. Benzo(a)pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis (Lond.), 18: 795-799, 1997.
4. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
5. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87: 803-809, 1996.
6. Tsujii, M., Kawano, S., and DuBois, R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA, 94: 3336-3340, 1997.
7. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
8. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996.
9. Sheng, G. G., Shao, J., Sheng, H., Hooton, E. B., Isakson, P. C., Morrow, J. D., Coffey, R. J., DuBois, R. N., and Beauchamp, R. D. A selective cyclooxygenase inhibitor suppresses the growth of H-rastransformed rat intestinal epithelial cells. Gastroenterology, 113: 1883-1891, 1997.
10. Kawamori, T., Rao, C. V., Seibert, K., and Reddy. B. S. Chemo-preventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58: 409-412, 1998.
11. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., and Otomo, S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47: 55-59, 1994.
12. Phillips, R. K. S., Wallace, M. H., Lynch, P. M., Hawk, E., Gordon, G. B., Saunders, B. P., Wakabayashi, N., Shen, Y., Zimmerman, S., Godio, L., Rodrigues-Bigas, M., Su, L-K., Sherman, J., Kelloff, G., Levin, B., and Stinbach, G., the FAP Study Group. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut, 50: 857-860, 2002.
13. Perkins, T. M., and Shklar, G. Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin. Oral Surg. Oral Med. Oral Pathol., 53: 170-178, 1982.
14. Cornwall, H., Odukoya, O., and Shklar, G. Oral mucosal tumor inhibition by ibuprofen. J. Oral. Maxillofac. Surg., 41: 795-800, 1983.
15. Panje, W. R. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch. Otolaryngol., 107: 658-663, 1981.
16. Nishimura, G., Yanoma, S., Mizuno, H., Kawakami, K., and Tsukuda, M. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells. Jpn. J. Cancer Res., 90: 1152-1162, 1999.
17. Shiotani, H., Denda, A., Yamamoto, K., Kitayama, W., Endoh, T., Sasaki, Y., Tsutsumi, N., Sugimura, M., and Konishi, Y. Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide. Cancer Res., 61: 1451-1456, 2001.
18. Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. I., and Rigas, B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52: 237-245, 1996.
19. Elder, D. J. E., Halton, D. E., Hague, A., and Paraskeva, C. Induction of apoptotic cell death in human colon carcinoma cell lines by a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug. Clin. Cancer Res., 3: 1679-1683, 1997.
20. Prime, S. S., Nixon, S. V. R., Crane, I. J., Stone, A., Matthews, J. B., Maitland, N. J., Remnant, L., Powell, S. K., Game, S. M., and Scully, C. The behaviour of human oral squamous cell carcinoma in cell culture. J. Pathol., 160: 259-269, 1990.
21. Edington, K. G., Loughran, O. P., Berry, I. J., and Parkinson, E. K. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol. Carcinog., 13: 254-265, 1995.
22. Fahey, M. S., Paterson, I. C., Stone, A., Collier, A. J., Heung, Y. L., Davies, M., Patel, V., Parkinson, E. K., and Prime, S. S. Dysregulation of autocrine TGF-β isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts. Br. J. Cancer, 74: 1074-1080, 1996.
23. Yeudall, W. A., Paterson, I. C., Patel, V., and Prime, S. S. Presence of human papillomavirus sequences in tumour-derived human oral keratinocytes expressing mutant p53. Eur. J. Cancer B Oral Oncol., 31B: 136-143, 1995.
24. Rheinwald, J. G., and Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell, 6: 331-344, 1975.
25. Miller, D. R., Allison, D. P., Rorvik, M. C., and Slaga, T. J. Inhibited morphological terminal differentiation and enhanced proliferation of cultured mouse epidermal cells at different concentrations of dimethyl sulphoxide. Cell Prolif., 24: 191-201, 1991.
26. Elder, D. J. E., Halton, D. E., Crew, T. E., and Paraskeva, C. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2 selective non-steroidal anti-inflammatory drug NS-398. Int. J. Cancer, 86: 553-560, 2000.
27. Li, M., Wu, X., and Xu, X. C. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin. Cancer Res., 7: 1010-1016, 2001.
28. Li, M., Wu, X., and Xu, X. C. Induction of apoptosis by cyclooxygenase-2 inhibitor NS398 through a cytochrome c dependent pathway in esophageal cancer cells. Int. J. Cancer, 93: 218-223, 2001.
29. El Attar, T. M., and Lin, H. S. Prostaglandin synthesis by squamous carcinoma cells of head and neck, and its inhibition by non-steroidal anti-inflammatory drugs. J. Oral Pathol., 16: 483-487, 1987.
30. Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimäki, A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58: 4997-5001, 1998.
31. Mohammed, S. I., Knapp, D. W., Bostwick, D. G., Foster, R. S., Khan, K. N., Masferrer, J. L., Woerner, B. M., Snyder, P. W., and Koki, A. T. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res., 59: 5647-5650, 1999.
32. Langdon, J. D. Classification and staging. In: J. D. Langdon and J. M. Henk (eds.), Malignant Tumours of the Mouth. Jaws and Salivary Glands, pp. 36-44. London: Edward Arnold, 1995.
33. Otto, J. C., DeWitt, D. L., and Smith, W. L. N-Glycosylation of prostaglandin endoperoxidase synthases-1 and -2 and their orientations in the endoplasmic reticulum. J. Biol. Chem., 268: 18234-18242, 1993.
34. Hague, A., Manning, A. M., Hanlon, K. A., Huschtscha, L. I., Hart, D., and Paraskeva, C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer, 55: 498-505, 1993.
35. Watt, F. M. Involucrin and other markers of keratinocyte terminal differentiation. J. Investig. Dermatol., 81 (Suppl. 1): 100s-103s, 1983.
36. Yu, C. C., Woods, A. L., and Levison. D. A. The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem. J., 24: 121-131, 1992.
37. Toyoshima, T., Kamijo, R., Takizawa, K., Sumitani, K., Ito, D., and Nagumo, M. Inhibitor of cyclooxygenase-2 induces cell cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21. Br. J. Cancer, 86: 1150-1156, 2002.
38. KIP1 as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells. Mol. Pharmacol., 58: 1398-1403, 2000.
39. Chan, G., Boyle, J. O., Yand, E. K., Zhang, F., Sacks, P. G., Shah, J. P., Edelstein, D., Soslow, R. A., Koki, A. T., Woener, B. M., Masferrer, J. L., and Dannenberg, A. J. Cyclooxygenase-2 expression is upregulated in squamous cell carcinoma of the head and neck. Cancer Res., 59: 991-994, 1999.
40. Nathan, C. O., Leskov, I. L., Lin, M., Abreo, F. W., Shi, R., Hartman, G. H., and Glass, J. COX-2 expression in dysplasia of the head and neck: correlation with eIF4E. Cancer (Phila.), 92: 1888-1895, 2001.
41. Jaeckel, E. C., Raja, S., Tan, J., Das, S. K., Dey, S. K., Girod, D. A., Tsue, T. T., and Sanford, T. R. Corrrelation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor δ with head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 127: 1253-1259, 2001.
42. Renkonen, J., Wolff, H., and Paavonen, T. Expression of cyclooxygenase-2 in human tongue carcinoma and its precursor lesions. Virchows Arch., 440: 594-597, 2002.
43. Subbaramaiah, K., Altorki, N., Chung, W. J., Mestre, J. R., Sampat, A., and Dannenberg, A. J. Inhibition of cyclooxygenase-2 gene expression by p53. J. Biol. Chem., 274: 10911-10915, 1999.
44. Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., and Dannenberg, A. J. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. Cancer Res., 57: 2890-2895, 1997.
45. Yuan, C. J., Mandal, A. K., Zhang, Z., and Mukherjee, A. B. Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal anti-inflammatory drugs. Cancer Res., 60: 1084-1091, 2000.
46. Liu, X. H., Yao, S., Kirschenbaum, A., and Levine, A. C. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res., 58: 4245-4249, 1998.
47. Zimmermann, K. C., Sarbia, M., Weber, A. A., Borchard, F., Gabbert, H. E., and Schrör, K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res., 59: 198-204, 1999.
48. Bae, S. H., Jung, E. S., Park, Y. M., Kim, B. S., Kim, B. K., Kim, D. G., and Ryu, W. S. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin. Cancer Res., 7: 1410-1418, 2001.
49. Thurnher, D., Bakroeva, M., Formanek, M., Knerer, B., and Kornfehl, J. Non-steroidal anti-inflammatory drugs inhibit telomerase activity in head and neck squamous carcinoma cell lines. Head Neck, 23: 1049-1055, 2001.
50. 2 and vitamin E succinate. J. Oral Pathol. Med., 22: 425-427, 1993.
51. Chan, T. A., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mechanisms underlying nonsteroidal anti-inflammatory drug-induced apoptosis. Proc. Natl. Acad. Sci. USA, 95: 681-686, 1998.
52. Chang, H. C., and Weng, C. F. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells. Oncol. Rep., 8: 1321-1325, 2001.
53. Joki, T., Heese, O., Nikas, D. C., Bello, L., Zhang, J., Kraeft, S. K., Seyfried, N. T., Abe, T., Chen, L. B., Carroll, R. S., and Black, P. M. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res., 60: 4926-4931, 2000.